產(chǎn)品描述

塔望科技提供全系列的動(dòng)物實(shí)驗(yàn)用低/高氧控制產(chǎn)品，包括恒定濃度控制的低氧動(dòng)物箱、高氧動(dòng)物箱、可編程的間歇氧濃度控制系統(tǒng)、帶緩沖艙的手套低氧箱等。整套低氧/高氧實(shí)驗(yàn)箱裝置主要由氧氣控制器和動(dòng)物實(shí)驗(yàn)箱兩部分組成。另可提供多種不同的氣體控制器，滿(mǎn)足不同實(shí)驗(yàn)O2、CO2、NO、CO、O3等氣體濃度控制的需求。

Ox-100動(dòng)物低氧實(shí)驗(yàn)系統(tǒng)可以控制動(dòng)物實(shí)驗(yàn)箱內(nèi)持續(xù)低氧的環(huán)境，用以制造相關(guān)的低氧實(shí)驗(yàn)?zāi)Ｐ汀Ｓ脩?hù)可自由設(shè)置所需要的濃度和實(shí)驗(yàn)持續(xù)時(shí)間，所有的設(shè)置通過(guò)控制主機(jī)觸摸屏完成，人性化設(shè)計(jì)，操作簡(jiǎn)便。

Ox-100動(dòng)物低氧實(shí)驗(yàn)系統(tǒng)監(jiān)測(cè)指標(biāo)全面，動(dòng)物低氧艙內(nèi)具有集成化的傳感器模塊，內(nèi)置溫度、濕度、氧氣、二氧化碳傳感器。可以實(shí)時(shí)監(jiān)測(cè)動(dòng)物低氧艙內(nèi)的環(huán)境。系統(tǒng)通過(guò)閉環(huán)反饋控制，根據(jù)動(dòng)物低氧艙內(nèi)的氧濃度實(shí)時(shí)反饋控制，使動(dòng)物實(shí)驗(yàn)低氧數(shù)據(jù)更準(zhǔn)確，避免了控制型濃度輸出和低氧艙內(nèi)濃度不一致的情況。Ox-100動(dòng)物低氧實(shí)驗(yàn)系統(tǒng)具有優(yōu)良的控制性能，持續(xù)低氧實(shí)驗(yàn)時(shí)，氧濃度的誤差為0.1%。

Ox-100動(dòng)物低氧實(shí)驗(yàn)系統(tǒng)提供不同尺寸的動(dòng)物低氧箱，默認(rèn)低氧箱可放置1個(gè)大鼠籠（或2個(gè)小鼠籠），同時(shí)提供大號(hào)規(guī)格，可容納2個(gè)大鼠籠和4個(gè)大鼠籠。如需其它規(guī)格，可提供定制。

如需高氧實(shí)驗(yàn)，請(qǐng)選擇型號(hào)Ox-100HE。

產(chǎn)品特點(diǎn)及參數(shù)

1. 為動(dòng)物低氧實(shí)驗(yàn)?zāi)Ｐ偷慕⑻峁┓€(wěn)定的低氧環(huán)境

2. 按照設(shè)定氣體濃度自動(dòng)配比氣體，維持恒定的氧氣濃度環(huán)境。無(wú)需在箱體外混合比例氣體，實(shí)驗(yàn)氧濃度的準(zhǔn)確，節(jié)省氣源

3. 艙體采用全透明PMMA材質(zhì)，防止由于光線(xiàn)影響動(dòng)物生物節(jié)律

4. 7英寸大屏觸摸屏控制，人性化界面，操作簡(jiǎn)單

5. 監(jiān)測(cè)參數(shù)：溫度、濕度、氧氣O2濃度、二氧化碳濃度

6. 控制精度：±0.1%

7. 非色散紅外（NDIR）二氧化碳傳感器，測(cè)量范圍：0～5000ppm

8. 進(jìn)口電化學(xué)氧氣O2濃度檢測(cè)器，測(cè)量范圍：0-25%vol，線(xiàn)性度好，檢測(cè)準(zhǔn)確、使用壽命長(zhǎng)。具有溫度補(bǔ)償機(jī)制

9. 溫度檢測(cè)：進(jìn)口高精度溫度傳感器

10. 氧氣濃度變化動(dòng)態(tài)曲線(xiàn)，直觀了解氧氣濃度變化的過(guò)程

11. 具有定時(shí)功能，實(shí)驗(yàn)完成，自動(dòng)恢復(fù)常氧狀態(tài)，并伴有聲音提示

12. 氧氣濃度自動(dòng)校準(zhǔn)：通過(guò)控制器對(duì)傳感器快速校準(zhǔn)

13. *的氣體混合及循環(huán)機(jī)制，保證箱體內(nèi)氣體濃度的均一

14. 高性能電磁閥，性能穩(wěn)定，超長(zhǎng)壽命

15. 艙體尺寸有多種選擇，可靈活搭配。也可根據(jù)實(shí)驗(yàn)要求進(jìn)行定制

ProOx-100動(dòng)物間歇低氧實(shí)驗(yàn)系統(tǒng)多功能控制

可進(jìn)行間歇低氧實(shí)驗(yàn)（CIH）、急性缺氧實(shí)驗(yàn)、慢性缺氧實(shí)驗(yàn)、高氧/低氧交替實(shí)驗(yàn)

應(yīng)用領(lǐng)域

肺動(dòng)脈高壓、腎臟疾病研究、腫瘤研究、心血管疾病研究、視網(wǎng)膜病變、運(yùn)動(dòng)醫(yī)學(xué)研究、OSAHS、腦發(fā)育與神經(jīng)生物學(xué)、干細(xì)胞研究、醫(yī)學(xué)研究等

型號(hào)說(shuō)明

艙體型號(hào)（可選擇不同尺寸的低氧艙）

*我公司可提供3Q驗(yàn)證，根據(jù)客戶(hù)的特殊應(yīng)用、特殊需求提供功能定制服務(wù)，也可以提供相關(guān)的實(shí)驗(yàn)服務(wù)，詳情請(qǐng)來(lái)電問(wèn)詢(xún)。

引用文獻(xiàn)

[1]Liang Xie, Qinhan Wu, Weiping Hu,Xu Wu,Guiling Xiang,Shengyu Hao, Han Guo,Shanqun Li(2020) ,Impact of histaminergic H3 receptor antagonist on hypoglossal nucleus in chronic intermittent hypoxia conditions,Psychopharmacology,. 2021 Jan;238(1):121-131. doi: 10.1007/s00213-020-05663-0. Epub 2020 Sep 22.

[2]Xu Y, Kong X, Li J, Cui T, Wei Y, Xu J, Zhu Y , Zhu X. “Mild Hypoxia Enhances the Expression of HIF and VEGF and Triggers the Response to Injury in Rat Kidneys." [J]. Front. Physiol. 12:690496. doi: 10.3389/fphys.2021.690496

[3]Liang Xie, Qinhan Wu, Weiping Hu, Xu Wu, Guiling Xiang, Shengyu Hao, Han Guo, Shanqun Li. “Impact of histaminergic H3 receptor antagonist on hypoglossal nucleus in chronic intermittent hypoxia conditions." [J]. Psychopharmacology.

[4]Li Huang, Tianyou Li, Min Zhou, Mengyan Deng, Lidong Zhang, Long Yi, Jundong Zhu, Xiaohui Zhu, Mantian Mi. “Hypoxia Improves Endurance Performance by Enhancing Short Chain Fatty Acids Production via Gut Microbiota Remodeling." [J]. Front. Microbiol. 12:820691

[5]Yanhong Pei a b, Lifei Huang c, Tong Wang c, Qinhan Yao a, Yanrong Sun a, Yan Zhang a, Xiaomei Yang a, Jiliang Zhai d, Lihua Qin a, Jiajia Xue c, Xing Wang c, Hongquan Zhang a b, Junhao Yan."Bone marrow mesenchymal stem cells loaded into hydrogel/nanofiber composite scaffolds ameliorate ischemic brain injury. materialstoday ADVANCES, Volume 17, March 2023, 100349.

[6]Zhang, C., Sun, Y., Guo, Y. et al. “JMJD1C promotes smooth muscle cell proliferation by activating glycolysis in pulmonary arterial hypertension. “[J].Cell Death Discov. 9, 98 (2023).

[7]Fang Zhao, Yan Meng, Yue Wang, Siqi Fan, Yu Liu,Xiangfeng Zhang, Chenyang Ran, Hongxin Wang and Meili Lu. "Protective effect of Astragaloside IV on chronic intermittent hypoxia-induced vascular endothelial dysfunction through the calpain-1/SIRT1/AMPK signaling pathway" .[J]. Frontiers in Pharmacology,10.3389/fphar.2022.920977

[8]Chenyu Xu, Jun Xu, Chunfang Zou, Qian Li, Shan Mao, Ying Shi, Yan Tan, Wei Gu, Liang Ye. "Chronic Intermittent Hypoxia Regulates CaMKII-Dependent MAPK Signaling to Promote the Initiation of Abdominal Aortic Aneurysm."  [J]. Hindawi, Oxidative Medicine and Cellular Longevity Volume 2021, Article ID 2502324, 15 pages

[9]Jing Zhang, Jian-Zhong Jiang, Jun Xu, Chen-Yu Xu, Shan Mao, Ying Shi, Wei Gu, Chun-Fang Zou, Yue-Ming Zhao,  Liang Ye. "Identification of Novel Biomarkers for Abdominal Aortic Aneurysm Promoted by Obstructive Sleep Apnea." [J].  Elsevier Inc. This is an open access article under the CC BY-NC-ND license

[10]Zhang Q, Xu L, Bai Y, Chen P, Xing M, Cai F, Wu Y,  Song W. “Intermittent hypoxia-induced enhancement of sociability and working memory associates with CNTNAP2 upregulation." [J]. Front. Mol. Neurosci. 16:1155047.

[11]Chen Zhang, Yue Sun, Yingying Guo, Jingjing Xu, Haiyan Zhao. “JMJD1C promotes smooth muscle cell proliferation by activating glycolysis in pulmonary arterial hypertension." [J]. Cell Death Discovery (2023) 9:98.

[12]Haimei Lun, Ruochuan Liu, Qiao Hu, Yaoli Liu, Lisi Wei, Xia Liu, Dan Wu, Shangyong Zhu,Contrast?Enhanced?Ultrasonography?of?Kidney?in?Chronic?Intermittent?Hypoxia?Rat?Model,[J]Journal of Ultrasound in Medicine,2022-12-07 ,DOI:10.1002/jum.16147